INM | INMED PHARMA | Owners

S&P 500$7,663.43
-1.21%
2m
DOW 30$52,867.98
+0.02%
2m
NASDAQ 100$28,958.69
-2.90%
2m
Russell 2000$276.67
+0.07%
2m
Russell 1000$417.25
-1.20%
2m
S&P 400$3,636.94
-0.79%
2m
S&P 600$1,686.53
+0.65%
2m

INMED PHARMA (INM)

NASDAQ

$1.35+$0.01 (+1.13%)

Price as of Oct 22, 2026 7:30 PM EDT

$7.5M
Market Cap
-33.98%
1-Year Change
Drug Manufacturers - Specialty & Generic
Industry

Top Holders

Institutional

Mutual Funds

Holder	Ownership %	Shares Held	Change (Shares, %)	Report Date
TWO SIGMA ADVISERS, LLC	3.75%	205,800	+205,800 (+100.00%)	Dec 31, 2021
TWO SIGMA INVESTMENTS LLC	2.40%	131,673	+131,673 (+100.00%)	Dec 31, 2021
TWO SIGMA INVESTMENTS, LP	0.72%	39,700	-91,973 (-231.67%)	Mar 31, 2022
EMPERY ASSET MANAGEMENT, LP	0.04%	2,470	+61,741 (+2,499.64%)	Mar 31, 2022
TWO SIGMA ADVISERS, LP	0.04%	1,932	-106,219 (-5,497.88%)	Jun 30, 2022
REILLY FINANCIAL ADVISORS, LLC	0.01%	700	+700 (+100.00%)	Dec 31, 2021
GEODE CAPITAL MANAGEMENT, LLC	0.01%	557	0 (0.00%)	Jun 30, 2022

Holder	Ownership %	Shares Held	Change (Shares, %)	Report Date
Blackstone Alternative Investment Funds	0.12%	6,495	+6,495 (+100.00%)	Jun 30, 2026

Current Ownership Distribution

Institutions4.7M (44.64%)
Mutual Funds3.8M (36.65%)
Insiders2.0M (18.71%)
Other0 (0.00%)

Insider Transactions

18.71% (2.0M)
Current InsiderOwnership (%, shares)
1
Number of InsiderBuying (last 12 months)
$11.2M
Amount of InsiderBuying (last 12 months)
0
Number of InsiderSelling (last 12 months)
$0.00
Amount of InsiderSelling (last 12 months)

Insider Name & Title	Type	Date	Transaction Value	Shares	Share Price	Shares After Transactions
ADAR1 Capital Management, LLC	Buy	Oct 19, 2026	$1,433.52	1,086	$1.32	956,580
ADAR1 Capital Management, LLC	Buy	Oct 16, 2026	$1.32	1	$1.32	955,494
ADAR1 Capital Management, LLC	Buy	Oct 15, 2026	$1,300.75	984	$1.32	955,493
ADAR1 Capital Management, LLC	Buy	Oct 14, 2026	$10,667.93	8,021	$1.33	954,509
ADAR1 Capital Management, LLC	Buy	Oct 13, 2026	$750.12	564	$1.33	946,488
ADAR1 Capital Management, LLC	Buy	Oct 05, 2026	$24,182.06	18,182	$1.33	935,021
ADAR1 Capital Management, LLC	Buy	Oct 02, 2026	$11,048.31	8,307	$1.33	916,839
ADAR1 Capital Management, LLC	Buy	Oct 01, 2026	$21,849.94	16,431	$1.33	908,532
ADAR1 Capital Management, LLC	Buy	Jul 15, 2026	$1,555.00	1,000	$1.55	801,000
Lemerond Nicole	Award	Dec 19, 2025	$0.00	1,750	$0.00	2,725
HSU ERIC C Sr. VP, Pre-Clinical Res/Dev	Award	Dec 19, 2025	$0.00	13,000	$0.00	18,280
Johnson Shane Aaron Sr VP & General Manager	Award	Dec 19, 2025	$0.00	8,500	$0.00	12,400
Klompas Neil A	Award	Dec 19, 2025	$0.00	1,750	$0.00	5,250
WOUDENBERG MICHAEL Chief Operating Officer	Award	Dec 19, 2025	$0.00	18,000	$0.00	25,445
Bathery John Steven	Award	Dec 19, 2025	$0.00	1,750	$0.00	5,250
Jagpal Netta Chief Financial Officer	Award	Dec 19, 2025	$0.00	18,000	$0.00	24,250
WOUDENBERG MICHAEL Chief Operating Officer	Expire Long	Dec 15, 2025	$0.00	60	$0.00	7,445
HSU ERIC C Sr. VP, Pre-Clinical Res/Dev	Expire Long	Dec 15, 2025	$0.00	70	$0.00	5,280
HULL ANDREW	Expire Long	Dec 15, 2025	$0.00	14	$0.00	961
Klompas Neil A	Award	Oct 17, 2025	$0.00	3,500	$0.00	3,500
HULL ANDREW	Expire Long	Jan 11, 2025	$0.00	2	$0.00	975
ADAMS ERIC A President & CEO	Award	Dec 20, 2024	$0.00	6,250	$0.00	14,300
HSU ERIC C Sr. VP, Pre-Clinical Res/Dev	Award	Dec 20, 2024	$0.00	2,750	$0.00	5,350
Jagpal Netta Chief Financial Officer	Award	Dec 20, 2024	$0.00	3,750	$0.00	6,250
Johnson Shane Aaron Sr VP & General Manager	Award	Dec 20, 2024	$0.00	1,500	$0.00	3,900
HULL ANDREW	Award	Dec 20, 2024	$0.00	550	$0.00	977
Baldasare Bryan T	Award	Dec 20, 2024	$0.00	550	$0.00	975
Grove Janet P	Award	Dec 20, 2024	$0.00	550	$0.00	975
Lemerond Nicole	Award	Dec 20, 2024	$0.00	550	$0.00	975